
Advance your small molecule from concept to clinic
Move your small molecule forward through discovery, IND and NDA submission with WuXi AppTec's integrated platform. Our comprehensive solutions address bioanalytical, DMPK, and toxicology testing needs while meeting your critical development timelines with expert scientific support at every stage.
Contact our team to learn about our full range of services and capabilities for small molecule development.
An end-to-end preclinical program
designed for your small molecule
Our end-to-end small molecule platform combines world-class analytics, experienced toxicologists, and global regulatory knowledge to navigate development hurdles and strengthen your submission package.
Bioanalysis
DMPK
Toxicology
Pharmacology
CMC
Regulatory Affairs
Your end-to-end preclinical testing partner
With capabilities in safety assessment, DMPK/ADME, bioanalytical, pharmacology, Chemistry, Manufacturing and Controls (CMC) and analytical services all under one roof, WuXi AppTec is a global expert in preclinical development testing and can support the full scope of your development program, from discovery to IND-enabling studies to NDA submission.